About
Inflammatory Treatments
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
0
As Collaborator
7
Total Enrollment
1,683
By Phase
PHASE2: 1PHASE3: 3
By Status
COMPLETED: 6WITHDRAWN: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
Today
Hover over trial bars to see details
Recent Trials
NCT02546154Collaborator
Time to Relapse of Iron Deficiency Anaemia After Standard Treatment With The Intravenous Iron (Monofer®)
N/ACompleted
359 participants
Started: Jan 22, 2016 · Completed: Dec 31, 2018
NCT02484768Collaborator
IV Iron Treatment of Restless Legs Syndrome
PHASE2Withdrawn
Started: Jan 31, 2015 · Completed: Feb 28, 2015
NCT02301026Collaborator
A Non-interventional Study of Diafer in Subjects With CKD on Haemodialysis for Treatment of Iron Deficiency
N/ACompleted
209 participants
Started: Sep 1, 2014 · Completed: Dec 9, 2016
NCT02130063Collaborator
IDA-01 A Randomised, Open-Label, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) and Iron Sucrose
PHASE3Completed
511 participants
Started: May 31, 2014 · Completed: Aug 31, 2015
NCT01900197Collaborator
Time to Relapse of Iron Deficiency Anemia After Standard Treatment With a New Intravenous Iron (Monofer®)
N/ACompleted
391 participants
Started: Aug 31, 2013 · Completed: Nov 30, 2015
Locations (1)
Headquarters
Cambridge, UK
Map
Loading map...